Press Releases
-
CD Genomics Unveils Cutting-Edge 5mC/5hmC Sequencing Service to Drive Epigenomics Research Forward
-
CD Genomics Takes Genomic Research to New Heights with Ribo-seq Technology
-
Sygnature Discovery appoints new industry leaders to their board of directors
I'm getting in touch with the latest news from Sygnature Discovery, a world-leading contract research organization. The company has recently appointed two industry leaders, Vanessa Malier and Martin LeBlanc, to their board of directors, reinforcing its commitment to innovation and strategic leadership. With decades of experience and a wealth of expertise in their respective fields, both Martin and Vanessa bring unique and valuable perspectives to Sygnature Discovery's board.
Nov 29, 2023
-
CD Genomics Launches Full-Length 16S/18S/ITS Amplicon Sequencing Service
-
Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC
-
Creative Enzymes Unveils Cutting-edge Homocysteine Methyltransferase, Recombinant for Enhanced Bioprocessing
-
Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant
-
IntegrateRNA Unveils Revolutionary Self-Amplifying RNA In Vitro Synthesis Service
-
Microbialtec Announces Industry-Leading Microbial Identification Services under GMP Standards
-
Creative Proteomics Uplifts Protein Research with Cutting-Edge Molecular Mass Determination Services
-
Creative Biogene Provides One-stop PEM-Seq Service to Assess Off-target Effect of CRISPR/Cas9
-
Creative Proteomics Unleashes the Exosome Untargeted Metabolomics Service
-
Creative Proteomics Enhances Proteomics Research with Advanced Post-Translational Modification Analysis Services
-
Samsung Biologics engages suppliers to advance global decarbonization targets
-
Amerigo Scientific Releases Automated Liquid Handling Equipment to Modernize Pipetting Workflow
-
CD Formulation Provides Efficient Strategies to Develop and Optimize Microspheres & Microneedles
-
Vast Range of Quantum Dots Available at Alfa Chemistry to Foster Innovations in Biotechnology, Optoelectronics, and Catalysis
-
Symbiosis Pharmaceutical Services granted MHRA licence following a £1M Investment
-
“Inizio Launch Elevate” Set to Help Global Pharma Maximize Product Launch Potential
Inizio has announced the new launch of “Inizio Launch Elevate” which aims to accelerate global pharma product launches, harnessing the power of its specialist product launch expertise with an enhanced commercial offering
Nov 19, 2023
-
BOC Sciences Celebrates Nobel Prize Awarded to Scientists Behind COVID-19 Vaccines
BOC Sciences expressed its congratulations to Katalin Karikó and Drew Weissman for being recipients of the 2023 Nobel Prize in Physiology or Medicine.
Nov 20, 2023